In response to the COVID-19 pandemic, my institution has implemented multiple procedures to protect patients and personnel from COVID-19 infection and avoid interruptions in cancer therapy.
Immunotherapies have revolutionized the treatment of metastatic recurrent head and neck cancer. In this commentary, I revisit the data behind current best practice and look ahead to new combination therapies.
Read my commentary to see my approach to patients with head and neck cancer and an NTRK gene fusion.
Read my commentary to see my approach to managing immunotherapy-related adverse events in patients with head and neck cancer.
Download these slides for quick highlights on treating patients with head and neck cancer with the latest biomarker-driven therapies.
Downloadable slides based on an expert video reviewing the current standard of care for your patients with advanced metastatic head and neck cancer.
Downloadable slides review the optimal use of immune checkpoint inhibitors in the frontline setting in patients with advanced metastatic head and neck cancer.
Downloadable slides review current clinical trials with immunotherapies for patients with advanced metastatic head and neck cancer.
Downloadable slides to review the rationale for treating NTRK fusions in patients with head and neck cancer.
Download these slides to review how and when to test for NTRK fusions in patients with head and neck cancer.
Download these slides to review the use of NTRK inhibitors in patients with head and neck cancer.
Download these slides for quick highlights of recommended management strategies for patients with head and neck cancer experiencing immune-related adverse events.
Download these slides for quick highlights on the importance of molecular testing for patients with head and neck cancer.
Download these slides for quick highlights on the role of the immune system and immune escape in patients with head and neck cancer.
Download these slides for quick highlights on immunotherapy biomarkers in patients with head and neck cancer.
Quickly access expert treatment recommendations for patients with advanced head and neck cancer with this decision tool.
Watch this brief expert video to review the current standard of care for your patients with advanced metastatic head and neck cancer.
Watch this brief expert video to review the optimal use of immune checkpoint inhibitors in the frontline setting in patients with advanced metastatic head and neck cancer.
Watch this brief expert video to review the future potential of immune checkpoint inhibitors in patients with head and neck cancer.
Watch this brief video with an expert to learn why testing for NTRK fusions in patients with head and neck cancer is recommended.
Watch this brief expert video to learn recommended strategies for testing for NTRK fusions in patients with head and neck cancer.
Watch this brief expert video to learn recommended treatment strategies for patients with head and neck cancer and NTRK fusions.
Watch this brief expert video to learn recommended management strategies for patients with head and neck cancer experiencing immune-related adverse events.
Watch this brief expert video on molecular testing for patients with head and neck cancer.
Watch this brief expert video on the role of the immune system and immune escape in patients with head and neck cancer.
Watch this brief expert video on the latest information on biomarkers for immunotherapy in patients with head and neck cancer.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.